Loading decisions…
Loading decisions…
46,961 vetted Board decisions for Ischemic heart disease.
The Board has remanded the Veteran's claims for increased evaluations for his service-connected coronary artery disease, status-post CABG. The VA examinations obtained prior to the hearing were inadequate and did not provide sufficient information for rating purposes.
The Board has remanded the claims for service connection for cardiomyopathy and coronary artery disease due to a pre-decisional duty to assist error. Additional development is needed regarding the Veteran's exposure to radiation, and an opinion from a qualified VA examiner is required.
The Board denied attorney fees for past-due benefits awarded in the February 2023 rating decision, as there was no qualifying review request on that decision. The appellant could not perform services warranting fees on this issue.
The Board has remanded the claims for service connection for heart condition, hypertension, BPH, thyroid condition, and sleep apnea due to potential toxic exposure risk activity (TERA).
The Veteran's chronic kidney disease with atherosclerotic cardiovascular disease and hypertension (post-myocardial infarction, coronary artery bypass graft) is rated at 100 percent effective May 9, 2019. The Veteran's diabetic neuropathy of the left upper extremity, right upper extremity, left lower extremity (femoral), and right lower extremity (sciatic) are all rated as 30 percent each. His left medial knee scar, anterior chest scar, and painful scars are all rated as non-compensable. The Veteran's service connection for chronic kidney disease with atherosclerotic cardiovascular disease and hypertension is granted effective May 9, 2019.
The Veteran's appeal of the TDIU claim was dismissed because the VA Form 10182 filed in January 2023 is untimely and did not appeal a rating decision within one year.
The Board has determined that the Veteran's cardiomyopathy is reasonably shown to be proximately due to his service-connected hypertension, and thus grants service connection for cardiomyopathy as secondary to hypertension.
The Veteran's request for a higher level review of his previously denied ischemic heart disease claim was found to be untimely and thus the appeal is dismissed.
The Board has remanded the claims of entitlement to service connection for atherosclerotic renal disease, headaches, cervical spine disability, and skin cancer due to pre-decisional duty to assist errors.,Service connection for angina is denied as there is no current diagnosis of angina or any related heart disability.
The Board has remanded the case due to insufficient evidence regarding whether the Veteran's heart disability is related to her service-connected asthma. The Veteran needs a new examination and opinion from an examiner.
The Veteran's claims of service connection for a psychiatric disorder (PTSD) and sleep dysfunction condition (OSA) are dismissed as moot due to the grant of these conditions in prior rating decisions.,Service connection for a heart disability is denied, with the Board finding that the Veteran's angina was not a separate disability from his service-connected GERD.
The Veteran's claim for service connection for coronary artery disease is granted due to exposure to herbicide agents during his service at a Royal Thai Air Force Base (RTAFB).,The Veteran's hypertension, diagnosed prior to the grant of presumptive service connection under the PACT Act, is also granted on this basis.
The Veteran's back, left knee, heart, skin cancer, headaches, and stomach/abdominal disabilities are remanded for further examination and opinion due to potential service connection based on toxic exposure.
The Veteran's kidney cancer is related to service and has been granted service connection.,The Veteran's coronary artery disease (CAD) from August 1, 2022, has been granted a rating of 100 percent.,The Veteran's hypertension has been granted an initial 20% rating.
The Veteran's TDIU claim is remanded due to the lack of recent evaluations for his heart condition, diabetes mellitus, and hypertension. The RO should order new examinations to assess these conditions.
The Veteran's initial rating for coronary artery disease (CAD) has been granted at a 30 percent level, effective from the date of the May 2023 agency decision.
The Veteran's tonsillar cancer is granted service connection based on presumed exposure to herbicide agents. The appeal for ischemic heart disease was dismissed as the Veteran withdrew his appeal.
Service connection for ischemic heart disease is granted on a direct basis due to exposure to herbicide agents during service in Guam.
The Veteran's claims for increased ratings for his service-connected conditions are being remanded due to the need for additional development and consideration.
The Veteran's claim for a higher rating for coronary artery disease from March 1, 2014, to the present was denied as his condition did not meet the criteria for a rating in excess of 30 percent.
← Back to Ischemic heart disease overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.